Isolation and characterization of novel RECK tumor suppressor gene splice variants
Winnischofer, Sheila Maria Brochado
Demasi, Marcos Angelo Almeida
Filho, Renato Astorino
Carreira, Ana Claudia Oliveira
de Assis Ribas, Thais
Konig, Michelle Silberspitz
Oba-Shinjo, Sueli Mieko
Marie, Suely Kazue Nagahashi
Sogayar, Mari CleideNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationTrombetta-Lima, M., S. M. B. Winnischofer, M. A. A. Demasi, R. A. Filho, A. C. O. Carreira, B. Wei, T. de Assis Ribas, et al. 2015. “Isolation and characterization of novel RECK tumor suppressor gene splice variants.” Oncotarget 6 (32): 33120-33133.
AbstractGlioblastoma multiforme is the most common and lethal of the central nervous system glial-derived tumors. RECK suppresses tumor invasion by negatively regulating at least three members of the matrix metalloproteinase family: MMP-9, MMP-2, and MT1-MMP. A positive correlation has been observed between the abundance of RECK expression in tumor samples and a more favorable prognosis for patients with several types of tumors. In the present study, novel alternatively spliced variants of the RECK gene: RECK-B and RECK-I were isolated by RT-PCR and sequenced. The expression levels and profiles of these alternative RECK transcripts, as well as canonical RECK were determined in tissue samples of malignant astrocytomas of different grades and in a normal tissue RNA panel by qRT-PCR. Our results show that higher canonical RECK expression, accompanied by a higher canonical to alternative transcript expression ratio, positively correlates with higher overall survival rate after chemotherapeutic treatment of GBM patients. U87MG and T98G cells over-expressing the RECK-B alternative variant display higher anchorage-independent clonal growth and do not display modulation of, respectively, MMP-2 and MMP-9 expression. Our findings suggest that RECK transcript variants might have opposite roles in GBM biology and the ratio of their expression levels may be informative for the prognostic outcome of GBM patients.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:26318645
- HMS Scholarly Articles